Bausch & Lomb (BLCO) Cash from Financing Activities (2021 - 2026)
Bausch & Lomb (BLCO) posted Cash from Financing Activities of -$20.0 million for Q1 2026, down 117.24% on a QoQ basis from $116.0 million in Q4 2025, and down 164.52% year-over-year from $31.0 million in Q1 2025.
Bausch & Lomb (BLCO) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Bausch & Lomb's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at -$20.0 million for Q1 2026.
- Quarterly Cash from Financing Activities fell 164.52% year-over-year to -$20.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174.0 million (down 11.68% YoY) and the FY2025 annual result came in at $225.0 million, up 26.4% from the prior year.
- Cash from Financing Activities was -$20.0 million for Q1 2026 at Bausch & Lomb, down from $116.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.8 billion in Q3 2023 and bottomed at -$109.0 million in Q3 2022.
- A 5-year average of $149.5 million and a median of $52.0 million in 2022 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities surged 1761.47% — and 2026, when it sank 164.52%.
- Bausch & Lomb's Cash from Financing Activities stood at -$7.0 million in 2022, then surged by 1328.57% to $86.0 million in 2023, then surged by 69.77% to $146.0 million in 2024, then decreased by 20.55% to $116.0 million in 2025, then slumped by 117.24% to -$20.0 million in 2026.
- Business Quant data shows BLCO's Cash from Financing Activities at -$20.0 million in Q1 2026, $116.0 million in Q4 2025, and -$12.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn | -20.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.00 Mn |
| Mar 31, 2026 | -20.00 Mn |
| Dec 31, 2025 | 116.00 Mn |
| Dec 31, 2025 | 116.00 Mn |
| Sep 30, 2025 | -12.00 Mn |
| Sep 30, 2025 | -12.00 Mn |
| Jun 30, 2025 | 90.00 Mn |
| Jun 30, 2025 | 90.00 Mn |
| Mar 31, 2025 | 31.00 Mn |
| Mar 31, 2025 | 31.00 Mn |
| Dec 31, 2024 | 146.00 Mn |
| Dec 31, 2024 | 146.00 Mn |
| Sep 30, 2024 | -20.00 Mn |
| Sep 30, 2024 | -20.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 86.00 Mn |
| Dec 31, 2023 | 86.00 Mn |